by admin_63069 | Jun 13, 2022 | Related Topics
How the disease can lead to an embracing of feminine identity
by admin_63069 | Jun 10, 2022 | Related Topics
Dr. Alicia Morgans is joined by Dr. Bertrand Tombal, who provides a European perspective highlighting prostate cancer data we have seen so far this year.
by admin_63069 | Jun 6, 2022 | Related Topics
An innovative immunotherapy option for metastatic castration-resistant prostate cancer
by admin_63069 | Jun 2, 2022 | Related Topics
Relugolix shown to have an acceptable toxicity profile with favorable tolerability in patients with advanced prostate cancer
by admin_63069 | May 29, 2022 | Related Topics
Efficacy consistent, regardless of prior therapy
by admin_63069 | May 25, 2022 | Related Topics
From the American Urological Association 2021 Annual Meeting
